U.S. Biosimilars Market Set for Rapid Growth Forecast 2020-2026: Key Players: F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co., Celltrion Inc. Others
The "U.S. Biosimilars Market 2020" will gain momentum from the increasing government support to adopt biosimilars in the healthcare sectors. According to a report by Fortune Business Insights, titled, "Biosimilars: U.S. Market Analysis, Insights and Forecast, 2019-2026," The U.S. Biosimilars Market is projected to reach US$ 17,696.0 Mn by 2026. The report provides valuable insights into the drivers influencing growth of the market. As per the report, The U.S. Biosimilars Market is anticipated to report an impressive CAGR of 54.7%...
View full press release